{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:06:29Z","timestamp":1792857989744,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945119"],"award-info":[{"award-number":["945119"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Electroanatomical mapping (EAM)-guided stereotactic arrhythmia radioablation (STAR) is a\u00a0novel noninvasive therapy option for patients with monomorphic ventricular tachycardia (VT) refractory to antiarrhythmic drugs and\/or urgent catheter ablation (CA). Data on success rates in an emergency situation such as electrical storm (ES) are rare. We present a\u00a0case of a\u00a0patient with an initially very poor life expectancy after extensive myocardial infarction with therapy\u2013resistant ES, not amendable for further antiarrhythmic drug therapy, implantable cardioverter-defibrillator implantation, or repeated CA who was introduced to the radiation oncology department for emergency STAR as a\u00a0bail-out therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Target volume definition and transfer from EAM to CT were validated and quality assured with a\u00a0semi-automatic, dedicated visualization tool (CARDIO-RT). Emergency STAR was performed with 25\u202fGy in the framework of the RAVENTA study. The VT burden gradually decreased after STAR; however, a\u00a0second VT morphology occurred, which was successfully treated with EAM-guided CA 12\u00a0days after STAR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The second EAM-guided CA showed areas of low voltage in the irradiated segments, indicating a\u00a0precise targeting and early functional response to STAR. The patient remained free of any VT recurrence or any radiation-related toxicities and in good general condition during the recent follow-up of 18\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The case highlights the possible approach, caveats, difficulties, and prognosis of a\u00a0patient severely affected by therapy-resistant VT in whom CA could not lead to VT suppression. Further studies of putative mechanisms of STAR in the acute and chronic phase of this novel therapy are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-023-02136-z","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T07:02:12Z","timestamp":1694502132000},"page":"1018-1024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Electroanatomical mapping after cardiac radioablation for treatment of incessant electrical storm: a\u00a0case report from the RAVENTA trial"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-6332","authenticated-orcid":false,"given":"Lena","family":"Kaestner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Boda-Heggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fanslau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Schweikard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Rudic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"2136_CR1","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A, Blom\u00a0N, Borggrefe\u00a0M, Camm\u00a0J, Elliott\u00a0PM, Fitzsimons\u00a0D, Hatala\u00a0R, Hindricks\u00a0G, Kirchhof\u00a0P, Kjeldsen\u00a0K, Kuck\u00a0KH, Hernandez-Madrid\u00a0A, Nikolaou\u00a0N, Norekval\u00a0TM, Spaulding\u00a0C, Van Veldhuisen\u00a0DJ, Group ESCSD (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart\u00a0J 36:2793\u20132867. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"2136_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.hrcr.2019.03.004","volume":"5","author":"EP Scholz","year":"2019","unstructured":"Scholz\u00a0EP, Seidensaal\u00a0K, Naumann\u00a0P, Andre\u00a0F, Katus\u00a0HA, Debus\u00a0J (2019) Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a\u00a0patient with refractory ventricular fibrillation storm. Hear Case Rep 5:329\u2013332. https:\/\/doi.org\/10.1016\/j.hrcr.2019.03.004","journal-title":"Hear Case Rep"},{"key":"2136_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijrobp.2021.01.028","volume":"110","author":"J Boda-Heggemann","year":"2021","unstructured":"Boda-Heggemann\u00a0J, Blanck\u00a0O, Mehrhof\u00a0F, Ernst\u00a0F, Buergy\u00a0D, Fleckenstein\u00a0J, Tulumen\u00a0E, Krug\u00a0D, Siebert\u00a0FA, Zaman\u00a0A, Kluge\u00a0AK, Parwani\u00a0AS, Andratschke\u00a0N, Mayinger\u00a0MC, Ehrbar\u00a0S, Saguner\u00a0AM, Celik\u00a0E, Baus\u00a0WW, Stauber\u00a0A, Vogel\u00a0L, Schweikard A, Budach\u00a0V, Dunst\u00a0J, Boldt\u00a0LH, Bonnemeier\u00a0H, Rudic\u00a0B (2021) Interdisciplinary clinical target volume generation for cardiac radioablation: multicenter benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. Int J Radiat Oncol Biol Phys 110:745\u2013756. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.01.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2136_CR4","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.adro.2022.100928","volume":"7","author":"MH van der Ree","year":"2022","unstructured":"van der Ree\u00a0MH, Visser\u00a0J, Planken\u00a0RN, Dieleman\u00a0EMT, Boekholdt SM, Balgobind\u00a0BV, Postema\u00a0PG (2022) Standardizing the cardiac radioablation targeting workflow: enabling semi-automated angulation and segmentation of the heart according to the American heart association segmented model. Adv Radiat Oncol 7:100928. https:\/\/doi.org\/10.1016\/j.adro.2022.100928","journal-title":"Adv Radiat Oncol"},{"key":"2136_CR5","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1111\/jce.14660","volume":"31","author":"S Hohmann","year":"2020","unstructured":"Hohmann\u00a0S, Henkenberens\u00a0C, Zormpas\u00a0C, Christiansen\u00a0H, Bauersachs\u00a0J, Duncker\u00a0D, Veltmann\u00a0C (2020) A\u00a0novel open-source software-based high-precision workflow for target definition in cardiac radioablation. J\u00a0Cardiovasc Electrophysiol 31:2689\u20132695. https:\/\/doi.org\/10.1111\/jce.14660","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2136_CR6","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","volume":"377","author":"PS Cuculich","year":"2017","unstructured":"Cuculich\u00a0PS, Schill\u00a0MR, Kashani\u00a0R, Mutic\u00a0S, Lang\u00a0A, Cooper\u00a0D, Faddis\u00a0M, Gleva\u00a0M, Noheria\u00a0A, Smith\u00a0TW, Hallahan\u00a0D, Rudy\u00a0Y, Robinson\u00a0CG (2017) Noninvasive cardiac radiation for ablation of ventricular tachycardia. N\u00a0Engl J Med 377:2325\u20132336. https:\/\/doi.org\/10.1056\/NEJMoa1613773","journal-title":"N Engl J Med"},{"key":"2136_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00066-021-01891-1","volume":"198","author":"O Blanck","year":"2022","unstructured":"Blanck\u00a0O, Boda-Heggemann\u00a0J, Hohmann\u00a0S, Mehrhof\u00a0F, Krug\u00a0D (2022) Cardiac stereotactic radiotherapy induces electrical conduction reprogramming. Strahlenther Onkol 198:209\u2013211. https:\/\/doi.org\/10.1007\/s00066-021-01891-1","journal-title":"Strahlenther Onkol"},{"key":"2136_CR8","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1038\/s41467-021-25730-0","volume":"12","author":"DM Zhang","year":"2021","unstructured":"Zhang\u00a0DM, Navara\u00a0R, Yin\u00a0T, Szymanski\u00a0J, Goldsztejn\u00a0U, Kenkel\u00a0C, Lang\u00a0A, Mpoy\u00a0C, Lipovsky\u00a0CE, Qiao\u00a0Y, Hicks\u00a0S, Li\u00a0G, Moore\u00a0KMS, Bergom\u00a0C, Rogers\u00a0BE, Robinson\u00a0CG, Cuculich\u00a0PS, Schwarz\u00a0JK, Rentschler\u00a0SL (2021) Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nat Commun 12:5558. https:\/\/doi.org\/10.1038\/s41467-021-25730-0","journal-title":"Nat Commun"},{"key":"2136_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00392-020-01650-9","volume":"109","author":"O Blanck","year":"2020","unstructured":"Blanck\u00a0O, Buergy\u00a0D, Vens\u00a0M, Eidinger\u00a0L, Zaman\u00a0A, Krug\u00a0D, Rudic\u00a0B, Boda-Heggemann\u00a0J, Giordano\u00a0FA, Boldt\u00a0LH, Mehrhof\u00a0F, Budach\u00a0V, Schweikard\u00a0A, Olbrich\u00a0D, K\u00f6nig\u00a0IR, Siebert\u00a0FA, Vonthein\u00a0R, Dunst\u00a0J, Bonnemeier\u00a0H (2020) Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a\u00a0German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol 109:1319\u20131332. https:\/\/doi.org\/10.1007\/s00392-020-01650-9","journal-title":"Clin Res Cardiol"},{"key":"2136_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijrobp.2022.06.056","volume":"114","author":"A Kluge","year":"2022","unstructured":"Kluge\u00a0A, Ehrbar\u00a0S, Grehn\u00a0M, Fleckenstein\u00a0J, Baus\u00a0WW, Siebert\u00a0FA, Schweikard\u00a0A, Andratschke\u00a0N, Mayinger\u00a0MC, Boda-Heggemann\u00a0J, Buergy\u00a0D, Celik\u00a0E, Krug\u00a0D, Kovacs\u00a0B, Saguner\u00a0AM, Rudic\u00a0B, Bergengruen\u00a0P, Boldt\u00a0LH, Stauber\u00a0A, Zaman\u00a0A, Bonnemeier\u00a0H, Dunst\u00a0J, Budach\u00a0V, Blanck\u00a0O, Mehrhof\u00a0F (2022) Treatment planning for cardiac radioablation: multicenter multiplatform benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. Int J Radiat Oncol Biol Phys 114:360\u2013372. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.06.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2136_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00066-019-01530-w","volume":"196","author":"D Krug","year":"2020","unstructured":"Krug\u00a0D, Blanck\u00a0O, Demming\u00a0T, Dottermusch\u00a0M, Koch\u00a0K, Hirt\u00a0M, Kotzott\u00a0L, Zaman\u00a0A, Eidinger\u00a0L, Siebert\u00a0FA, Dunst\u00a0J, Bonnemeier\u00a0H (2020) Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery) : first-in-patient treatment in Germany. Strahlenther Onkol 196:23\u201330. https:\/\/doi.org\/10.1007\/s00066-019-01530-w","journal-title":"Strahlenther Onkol"},{"key":"2136_CR12","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.hrthm.2021.08.004","volume":"18","author":"D Krug","year":"2021","unstructured":"Krug\u00a0D, Blanck\u00a0O, Andratschke\u00a0N, Guckenberger\u00a0M, Jumeau\u00a0R, Mehrhof\u00a0F, Boda-Heggemann\u00a0J, Seidensaal\u00a0K, Dunst\u00a0J, Pruvot\u00a0E, Scholz\u00a0E, Saguner\u00a0AM, Rudic\u00a0B, Boldt\u00a0LH, Bonnemeier\u00a0H (2021) Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia. Heart Rhythm 18:2137\u20132145. https:\/\/doi.org\/10.1016\/j.hrthm.2021.08.004","journal-title":"Heart Rhythm"},{"key":"2136_CR13","doi-asserted-by":"publisher","first-page":"989886","DOI":"10.3389\/fcvm.2022.989886","volume":"9","author":"J Whitaker","year":"2022","unstructured":"Whitaker\u00a0J, Zei\u00a0PC, Ahmad\u00a0S, Niederer\u00a0S, O\u2019Neill\u00a0M, Rinaldi\u00a0CA (2022) The effect of ionizing radiation through cardiac stereotactic body radiation therapy on myocardial tissue for refractory ventricular arrhythmias: a\u00a0review. Front Cardiovasc Med 9:989886. https:\/\/doi.org\/10.3389\/fcvm.2022.989886","journal-title":"Front Cardiovasc Med"},{"key":"2136_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.08.032","author":"J Whitaker","year":"2022","unstructured":"Whitaker\u00a0J, Bredfeldt\u00a0J, Williams\u00a0SE, Qian\u00a0P, Chang\u00a0D, Mak\u00a0RH, Cochet\u00a0H, Sauer\u00a0W, Zei\u00a0PC, Tedrow\u00a0U (2022) Ventricular conduction velocity following multimodal ablation including stereotactic body radiation therapy for refractory ventricular tachycardia. JACC Clin Electrophysiol. https:\/\/doi.org\/10.1016\/j.jacep.2022.08.032","journal-title":"JACC Clin. Electrophysiol."},{"key":"2136_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.hrthm.2022.04.017","volume":"19","author":"K Benali","year":"2022","unstructured":"Benali\u00a0K, Rigal\u00a0L, Simon\u00a0A, Bellec\u00a0J, Jais\u00a0P, Kamakura\u00a0T, Robinson\u00a0CG, Cuculich\u00a0P, De Crevoisier\u00a0R, Martins\u00a0RP (2022) Correlation between the radiation dose and myocardial remodeling after stereotactic radiation therapy for ventricular tachycardia: first assessment of the dose-effect relationship in humans. Heart Rhythm 19:1559\u20131560. https:\/\/doi.org\/10.1016\/j.hrthm.2022.04.017","journal-title":"Heart Rhythm"},{"key":"2136_CR16","doi-asserted-by":"publisher","first-page":"e019072","DOI":"10.1161\/JAHA.120.019072","volume":"10","author":"MJ Cha","year":"2021","unstructured":"Cha\u00a0MJ, Seo\u00a0JW, Kim\u00a0HJ, Kim\u00a0MK, Yoon\u00a0HS, Jo\u00a0SW, Oh\u00a0S, Chang\u00a0JH (2021) Early changes in rat heart after high-dose irradiation: implications for antiarrhythmic effects of cardiac radioablation. J\u00a0Am Heart Assoc 10:e19072. https:\/\/doi.org\/10.1161\/JAHA.120.019072","journal-title":"J Am Heart Assoc"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02136-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T18:03:34Z","timestamp":1698170614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02136-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02136-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<i>Financial interests:<\/i> L.\u00a0Kaestner: Speaker honoraria AstraZeneca GmbH. J.\u00a0Boda-Heggemann: EBAMed consulting fees outside of the study, Elekta research grant outside the study, speaker honoraria AstraZeneca GmbH. F.A.\u00a0Giordano: Honoraria, research grants and\/or travel support from Carl Zeiss Meditec AG, TME Pharma AG, Guerbet SA, Cureteq AG, Bristol-Myers Squibb, AstraZeneca GmbH, FoMF GmbH, MEDAC GmbH, Elsevier GmbH and stock\/ownership from TME Pharma AG and Implacit GmbH outside the submitted work. <i>Non-financial interests<\/i>: O.\u00a0Blanck is a\u00a0section editor in the journal <i>Strahlentherapie und Onkologie<\/i>. H.\u00a0Fanslau, J.\u00a0Xie, A.\u00a0Schweikard and B.\u00a0Rudic declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"<i>Ethics approval: <\/i>Approval was obtained from the ethics committee of University Heidelberg-Mannheim and Kiel. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. <i>Consent to participate\/publish:<\/i> Informed consent was obtained from all individual participants included in the study. The participant has consented to the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}